A Massachusetts doctor won’t have to face a second trial in a suit alleging that he failed to get a patient’s informed consent for an experimental treatment.
The patient’s estate failed to prove that a federal trial judge committed a series of evidentiary and instructional errors that required overturning the jury’s verdict for the physician, the US Court of Appeals for the First Circuit said Monday.
Edmund Ward undertook experimental medical care offered by the National Institutes of Health to treat a rare genetic deficiency in which his body failed to produce a blood enzyme that’s critical to cholesterol production, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.